Geneoscopy is developing a noninvasive, stool-based, preventive screening test to diagnose and treat colorectal cancer (CRC) in high-risk individuals with a methodology that is more accurate than a colonoscopy.

For more information, visit Geneoscopy or follow their updates on:

Locations

Financials

  • $7.9m

Geneoscopy Articles

Geneoscopy Raises Crazy Money

St. Louis Startup News Round-up: Denim and Pluton Raise Millions

Goldman Sachs Names St. Louis Co-founder in List of Most Intriguing Entrepreneurs

St. Louis’ Poop-Tech Startup

Geneoscopy Makes Key Hire

Geneoscopy Starts Human Colorectal Cancer Screening Trial

Geneoscopy Gets Key FDA Designation, Hires New Exec

It Takes a Village (and Universities Directly Engaging the Startup Ecosystem) to Retain Talent in St. Louis

Diagnostics Tool Developer Secures $1M in Funding to Detect GI Disease

Geneoscopy Raises $1 million

5 St. Louis entrepreneurs named Pipeline fellows

Strayos and Geneoscopy Win Wash U Global Impact Awards

The Agile Mission of BioGeneratorโ€™s Grants Program

Arcus Awards

Finalists Announced for 4th Annual St. Louis Regional Chamber Arcus Awards

Accelerate St. Louis Awards $120,000 in Prizes at Startup Connection 2016

Accelerate St. Louis Challenge 2015

Accelerate St. Louis Contest Finalists Announced, Winners to Be Announced During Global Entrepreneurship Week

Arch Grants Announces Summer 2016 Global Startup Competition Recipients

Greetabl Takes Top Prize at First TechCrunch Pitch-Off